A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

Clinical trial NCT07318805 · RECRUITING

Trial details

NCT number: NCT07318805
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Breast Cancer Metastatic Breast Cancer (HR+/ HER2-)Colorectal Cancer Metastatic Colorectal Adenocarcinoma Triple Negative Breast Cancer

Start date: 2025-12-23
Primary completion: 2029-04-14
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.